Pharmagreen Biotech Inc. operates as a biotechnology company with a focus on the production and development of plant-based pharmaceuticals. Utilizing advanced technologies in plant tissue culture and micropropagation, the company aims to produce high-quality cannabis clones, along with other botanicals, for both medical and recreational markets. Pharmagreen Biotech also contributes to sustainable agriculture and enhanced plant-growing methods, impacting the broader agricultural and biotech industries. The company positions itself as a significant player in biotech innovation, addressing growing demands in the medical cannabis sector while pursuing opportunities in the burgeoning market for plant-based therapies. Headquartered in North America, Pharmagreen continues to expand its reach by exploring new biotechnological solutions that can be applied in various sectors, underscoring its commitment to sustainable and scientifically-driven approaches.